Document is current
Any future updates will be listed below
-
Authors
Künzel, Robert
Faust, Helene
Bundalian, Linnaeus
Blüher, Matthias https://orcid.org/0000-0003-0208-2065
Jasaszwili, Mariami
Kirstein, Anna
Kobelt, Albrecht
Körner, Antje https://orcid.org/0000-0001-6001-0356
Popp, Denny
Wenzel, Eric https://orcid.org/0000-0003-2814-5634
Jamra, Rami Abou
Lemke, Johannes R. https://orcid.org/0000-0002-4435-6610
Schöneberg, Torsten https://orcid.org/0000-0001-5313-0237
Stein, Robert
Garten, Antje https://orcid.org/0000-0002-5354-287X
Le Duc, Diana https://orcid.org/0000-0001-7289-2552
- License Information
-
More Information
Article History
Received: 27 September 2024
Revised: 15 May 2025
Accepted: 29 May 2025
First Online: 16 June 2025
Competing interests
: MB received honoraria as a consultant and speaker from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Daiichi-Sankyo, Lilly, Novartis, Novo Nordisk, Pfizer, and Sanofi. The other authors declare no competing financial interests.
: This study was approved and monitored by the Ethics Committee of the University of Leipzig, Germany (224/16-ek and 402/16-ek) and was conducted in concordance to the declaration of Helsinki. All families provided written informed consent for genetic testing. Institutional ethics approval was not required if testing was part of routine clinical care.
